Eagle Eye CEO Touts Temperature Screening While Rushing
Eagle Eye's CEO Dean Drako is celebrating raising $40 million in an SSN interview where he was quoted touting temperature screening while people "walk, or run, by an entrance, and you can measure hundreds of people per minute".
Drako explained to IPVM that he was "not sure if [he] said run' or 'rush'" emphasizing that Eagle Eye cannot enforce FDA guidelines but do encourage following them.
Executive *******
********** **** *****'* **** *** ****** a ***** ***** ** **** *********** screening ******* *************** *** ********* *** ******** ***** giving ***** *** * *********** ********* against ********* **** ** ****** *** guidance *** ** *** ******* *** public **** ******** **** *********** ********* works ********** **** ******** ** ****** are ******* ** ******* ** *** minute.
**** ** ******* **** ******* ** why *** *** ***** ** ***** down ** ********** ********* *** ***** deployments.
SSN *********
**** ******* **, **** *** *********, ***** ***'* *** ****** *** temperature ******* ***** '**** ******'* ******** temperatures ** **** ****, ** ***, by ** ********, *** *** *** measure ******** ** ****** *** ******':
Clarification *** ********* ** ****
***** ***'* *** **** ** *** not **** ** ** **** '***' or '****' *** **** ** ***** SSN ** ****** *** ***** ** 'rush':
* ** *** **** ** * said "***" ** "****". **** * was ******* ***** **** ** ******* through * ****. ** **** **** deployments ** ******** **** ******* ******* that **** ************ ******** *** ************ of ****** ******** ******* ** ******** quite *******. ** **** **** ******* quite ********* **** ******** *** ********* by *** ****** ******* ** *** into ******. ** **** ***** **** to ******* *** ***** ** *** "rush" ** "***"
** *** *** **********, ***** ***'* CEO ********** **** ****** ******* ***** customers ** ****** **** *** **** nothing, ********* ******* ***** *** ***** manual ************ ** ********* ** *******:
*** *** ********** ** **** *** great. *******, ** ****** ******* **** on *** ********* - **** ** not *** ****. *********** ******** ** have **** ******* ******** **** *** reading ***** ******* ** ****** ** they ****** **** ********* ******* ****** or ******** *****. *** ********** *** been **** **** ********* ** * secondary ****** ** ****** **** ** flagged ** *********** ** ****** **** the ****** ******. ** *** **** these ******* *** *** ********* *** are *** *******. ******* **** ***** is *** ********* ** *******. * manual *********** ** *** ********* ** perfect. **** ***, *******, *** *****, that **** ***** *****.
**** ******* **** *** ******* ** that ** ****** ***** ******* "**** read ******’* ******** ************ ** **** walk, ** ***, ** ** ********, and *** *** ******* ******** ** people *** ******", ***** ***'* ******** endorsement ** **** *** ********* ******** is *********** ********* ** ****** ** in **** * *******. ***** ***'* CEO *********:
** ***** ***** ********** ** ********** encourage ********* ** *** ***********. ** statement *** ********* *** ** *** customers ***** *** ******* *******. ** is *** ***** ** ** *********** or ** *************. ***, ***** *** be **** **** ** ** ********** how ** **** **** **** ********* using ******* *******. ***** ** **** in **** ******.
*** ** *** '******** ***********' *******, Eagle ***'* *** ********** **** ********** 3rd ***** ********, ******** ** ******* inner ******* ** ****** **** ******** screening:
*** ***** *** ***** *** **** not **** ************. ** ******* ******* that **** ************. ** *** **** many ** *** ******* **** ********* elevated *********** ********* ** ** ** combining **** ********* **** * ******* camera. **** **** ** **** **** able ** ********* **** ******** ***********. Cameras **** *** **** *** ***** canthus ***** ** ******. ** **** support ***** ******* **** ********* *** and *** ************* ********* **** **. Eagle *** **** *** **** ** opinion ** ******* *** ***** ******* is ****** ** ********. ** ****** implement *** ******* **** *** ******* and ********* *** ** **** ** what ** ***.
** **-********** *** ***** **** ** control *** **** *** **** ** what ******* **** *******:
***** *** ******** ******** **** ********* cameras. *** **** *** ******** *** used ** ***** *** ******* ** our ******* *** *********. ** ******** in *** ******* **** ************ ** how **** *** ***** **** ** some ** *** *********. ** *** to ******* *** ********* *** ******* about ********, *** ** ****** *** should *** ******* ** ******* **** they **. ** ** *** ******* that ******** *********** ********* ******* *** a ******* ** **** **** ** not **** ***** ************.
**** ********* ** ****** **** ***** Eye **** **** / **-**** / white *********** (******** ****) *********** *********. ***** *********:
** ***** ******* ** * *********** to *** *******. * ***** *** say ** **** * ***** ***** "system", ** **** **** *** ***** label ******* *** ***** ****. ** you **** ******* ******* *** ***** been *** *****. **** ** *** deployments ** ******* ******* *** ******** with ***** *********' ******* ****** ** our *******. *** ******* ****** **** they **** *** *** **** **** to ****** **. ** ** ***** offer ***** ***** ******* **** ******* cameras ** *** *******. ** ********* they *** ********* *** *** ************* guidelines *** *** ***'* ****** *** information.
Eagle *** ** ***
***** ***'* *** ******* *** ******** of *** ***'* *********** ** **** of *** ********:
*** *** *** ******** **** ******** *********** (******* */**/****). ** *** ********* ** ******* to ** "***********". **** ** *** title ** ********* ** **********. ** does ******* *** "****** ***", ******* it ****** **** *** ********* "****** all ************ ************" ******** **** **** supersedes ***** "****** ***" ***********. ********** we ********* ** ** ********. **** before *** *** ********* **** *******, all ** **** ** ** *** included ** *** ******** *** *** own ***************. ** ** ******** ***** for ***** ******* *******. *** ******** of *** ********* *** *** *** customers ******* ********** *** *** ***********. Obviously ***** ********** **** **** *** best *** **** ******** *******. ** does ***, *******, **** **** ********* will *** **** ***** ** ***** them ** **** ***** **********. **** is ********* *** ******** ***** ** decide. ** **** *** ********* ** be ***** *** ** *** ***** thing. ** ********* ********* *** ***** the *** ***********.
******'* "*********** **********" ****** ***** **** addresses ************** *** ***'* ********* *** ****** to ************ *** ******** ************. ** obviously ****** *****.
FDA ***** ** *********
*****'* ******** ********** *** *** *** needs ** *********, ****** *** *****, on *** ********* *** ***********.
*** *******, ***** ****:
** ****** **** *** ********* "****** all ************ ************" ******** **** **** supersedes ***** "****** ***" ***********.
***** ** *** ******** *********** *** ***:
** * ****** ** ***** ****** systems, *** ***** ** ************ ************ trumping ***'* *** ****** *** *********** makes *****. ** **** *** ** us. *** ** **** *** **** scientific ** ********** *****, ***** ** is * ******** **** *** ************ can ****** ******** ************ **** ****.
*** ***, **** ** ***** *** May, *** *** ****** ***** **** ** ***+ *** ************ **** ******* ************ ********** **** made ** **** *** ***** ** see **** ***** *** ****** (****** running ** ******* **** **** ** from *** **** ** ****, ***.) were ********** ****** *****.
Thanks ** *****
*********, **** ***** ** *** *****. He ***** * **** **** ** salesmen ******* ***, ******* ****-***********, ********* fever ****** ******* ** **** **** put ****** ****** ** ****.
*** **** ** ******* **** ****, from * ****** ********** ************, ** why *** *** ***** ** ***** down ** ****** ************ ********* ** enforce ****** *** ****** *********.
***** *** ******* ****** ******* ******* misspoke * ******!!! *** ******** **** you ***** **** **** ** ****** out *** ** ***** *** ******* then ** *** *** ******** *** heard ** ** ****** *****' *********!!!
******* ******** * ******
******** ** **** '***' ** '****' does *** ****** *** ******* ** it ********* *** **********. *** ******** it '*** ******* ******** ** ****** *** minute' **** ** ****.
*******, * ***** *** ****** ***** is **** ***** **** ** ******** down *** ********* ** *** **********. It's ***** ** ***-****** **** *** a *** ****** *** ************ ***** decision.
** ******** **** ** *****'* ******** were *** ******** ********** ** ******** Temperature ********* (** ***).
**** ** *** **** **'* ******** EST (******** **** ***********) *********? ** is ** ****** ** * *** acronym ** *** *** ******* *** apparent ********** ** *** ******* ** measure ****** ****** ******* (******* ******* or ****** *******) *** ** *** same **** ** ****-********* ******** ***** and ******** *********** ********?
*******, ***** ******** **** ** ***** the******"*** **********" ********* ** ******* **** it *** ******** ** ** **** - *** ***** ***** * ******* of - *** ***************"*********** ********" ********.
"*********** ******** ** **** **** ******* deployed **** *** ******* ***** ******* of ****** ** **** ****** **** buildings ******* ****** ** ******** *****.Our ********** *** **** **** **** ********* ** * ********* ****** ** ****** **** ** ******* ** *********** ** ****** **** *** ****** ******."
**** ** *********.
*** ***** **** *** ***** **** thing ** ****** ***** * ******** paragraph ** ** ****** ** *****....
*****, **** * ******* ********* ** your ***** ******** *** **** ****** with **** ********** ********* **** *** nothing ** ** **** *** ******** sentence, ********** ** ******** *** ***** sentence.
*********** ******** ** **** **** ******* deployed **** *** ******* ***** ******* of ****** ** **** ****** **** buildings ******* ****** ** ******** *****
**** ** ***** *** ****** ****** truth ** **** * *********** ******. A ****** *** ** ******** **** reads ****** ********* **** * ******** that ******* ******** ******* *********** ********. However, **** **** *** **** *** system ** '********' ** **** ******** detect *** **** ****** *** **** have * ********** ******** ***********. **** is *** ***** ** **** **** in *** *******.
** ** ********** ****** *** *** camera *********** *** "*** ****". **** are ***** ********* ****** ******* ** is ********* ** **** *** *** doing*********, ** ******* ** ***** *******. Most *** ****** ****** *********** *** an ********** ***** ** ***** *** companies **** *** ****** ** "**-****" or ******* ********** **** * ********* society.
*** **** ********* **** **** ********* who **** ********* **** **** **** trained ** ******** ****** *** ****** and ******* ** ** *** ****** prescribed ** *** ************? *** **** customers **** ******* * ****** ******** space *** ********** ** *** ******, as ******* ** ****** ** *** it **** ***** ******** *****, ********, etc.? *** **** ********* **** **** and ***** ********* ** ******* ** in *** ****** ******* ** *** manufacturer? *** **** ********* **** ************ send *** ****** *** ***** **** in *** **-*********** *** **-************* ** required ** *** ************?
** **** *** **** *** ******** here ** **** **** **** **** customers **** **** ********* ** ***** systems *** *** ****** ******** ***** and ******* ***** ******** ********** ******** - ********** ** *** ********** ** the ********** *******. ** **** ** routinely *** ********* ******* *** "*********" that **** ** ******** ************ ******** - **** **** ** ****-********* ** the ******** ** ******** ******* * contractor **** *** *** ********, ******* cabling, ***. *** ********* **** ***** deployments **?
**********, ****'* ********** ******* *** *** systems **** ******** ** **** ** most *********, *** *** *** **** should ** **** ** ******** ****** an ******** ***********. *** *** ** wonder *** *** ********** *****'* *** FDA *********** ** ***** ********* ** important - ********** **** *** ********* of ******** *********** *** ********* ********* that *** **** ********* ***** *** one. **** *** **** * **** job ** ******* *** ******* ******* of ***** *****. *** ***** ***** interest ** *** ******* ***** ** stimulated **** * ******* ** *** articles ** **** **** **** *****.
************* *** ******** ** ****** ******** by *****-** *** ************. **** **** sail ***** **** ***** ******* *** infect ***** **-******* *** ****** **** know ***** ***** ********* ******** **** from.
*** *** ** ****** *** *** government *****'* *** *** *********** ** these ********* ** *********
* ***'* ******* ****'* *** *********** conclusion. *** ********** ** ******* **** a ***** ** *********** ****** (**** fake *********, *****, ***.) *** ******* through ****. * ** ******* ****, given ****, *** ********** **** ** something ****.
** *** ***** ** ********. **** the *** ******* *********:
"*** **** ***** * *********** **** in *** ******'* **************** **********. *** fulfills **** ************** ** ******** *** security ** *** **** ****** *** by ********* *********** ** ******* ******** to ******* ** ********** *** ********* emerging ****** ****** *******."
**** *** *** ******* ** ***** in *** ******* ***** ******* "******* equipment" **** **** ******* ************** *** regulations**************. ** ****** *** ***** *** to ******* **** * ********** ** being ******** *** ***** ****** / benefit ** ******** ********* ****** **** there *** ******** **********.
** **** *** *** ******* *** being ***** ** ***** ******* **** are ***** ** ** ***********. *** much **** ** ** **** *** FDA ** ******* *** *** **** these ******* *** ***** ******** ** schools *** *** ** ******* ********? What ***** ******* ******** ** ******* homes / ******** ****** ********** - where **** ** *** ******* **** people ****? **** ** ********* **** cannot ******.
*** ********* ******* ** *** *** is *********** ******* **** ****. *** skillset ** * ****** ********** *** effectiveness ** * ******* ** ***** likely **** ********* **** *** ******** of *** ****** ******** ** ******** an ********** *********** ********* ******. *'* sure ***** *** ****** *** ***** be ******** ** ********* **** **** as * ****** ******** *** *** immediate ****** ** *** *******. **** already **** ****** *** *** ********** the ******* ** ********* ** *** - *********** ** *** **** ******* in ********.
** *** ***** ** ********.
* ***'* ************ ********, ********* *** in *********. ** ***** ** **** that * ***'* ***** *** *** doesn't ***** **** ** ********* ** much ** **** ***** **** *****+ *** ********** ********* *** *** *** ** immediately ******* **.
***** *** *** **** ***** ** anything, ***** **** *** ********* ****** in *** ****** ****. ****, ******* ***** *** *** *** ** crackdown ** ****.
*'* **** ***** *** ****** *** could ** ******** ** ********* **** this ** * ****** ******** *** the ********* ****** ** *** *******.
* ** ***** **** **** **** people. *** ******** ** ***** **** are ** ** ***** *********** ** this.
***** *******! **** * *** * quote **** **** * **** **** he ** *** ********** ** *** circus. “**** *** *** ******* **** and **** *** – **** *****.” He ** * **** **** *********** and * **** ***********. * ******** wrapped ** ** ************ **** * global *********** ***** ******** ***** ** an *** ******** ****** ** ******* 400 ****** ** ***** ** *******. It **** * *** ** ****, but * ***** ** *** **** some **** ** ******** **** ***** more***************** ** ********* *********************** **** *** ***.
**** ** ***** ** *****-** *** really ******** ** **** * *** with * ******* ** ***** *** users *** **** ******* ** ******** solutions ** ****** ******** ** ******** on *** ******* ******. *** *** universal ***** **** *** ***** ***** was ************* *** ********** ********* ********** with *** *******. * ***** * hours ********** *** ***** **** * Global ******** ******** **** * ******* 100 ********* ******* **** ******** *** heard **. ** *** ******* *** much **** *** ************ ** ********* 45 ****. *** ******* ***** ** had *** *** ********* ********** **** the *******. *** ******* * **** with *****’* ****** ** ******** *** idea **** ****** ******* ** ******* through *** ******* **** ** **. If ** ******** ****** “******” ******* the ******* ****, *** **** ** it ***** ** **** ** ***** that ****** **** *** *** **** innocent ****** **** **** ** ******* with? **** ** *** ******** **** going ** **? *** ***** **** here ** ** ****** * ***** point ***** ****** **** ** ******** temperature *** **** *** ** *** facility. **** ****** ******** ******* *** going ** **** *** ******* **** outside ** *** ******** ** **** the ******** ****** **** ******** *** building ********** *** ************* ******. ** light ** ***** ***** ******** ****’* remarks ****** **** ********* ** *** topic ** * ******** ********** *** public ******. ** ** ********** **** the *** ****** **** ** **** sort ** **************.
* *** * ***** **** **** I **** **** ** ** *** ringleader ** *** ******.
***, * ***'* *** **** ** a ********** ** * ****** *** I ** ********* ***** *** ******* on **** ******. **** *** **********, I ***** **** ******* ** ***** have * **** ******** *********** *********** on ******...
*** ******* ***** ** *** *** the ********* ********** **** *** *******. The ******* * **** **** *****’* remark ** ******** *** **** **** people ******* ** ******* ******* *** testing **** ** **.
****. **** ***** ** ********** ** giving ********* **** **** ***** **, convenience *** ****** ********. **** **** by *** ** *** **** * fever ** **** *** ***. *** problem ** **** ** ** *** grounded ** ********** ******* *** **** cause **** ******** **** ****.
** **** ***** ** **** ** turn *** ********* ** *** *** and ******** **** ** ****** ******* with ***** "*********** ******".